Equities research analysts expect that Trupanion Inc (NASDAQ:TRUP) will report $65.60 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Trupanion’s earnings, with the highest sales estimate coming in at $65.90 million and the lowest estimate coming in at $65.30 million. Trupanion posted sales of $51.34 million in the same quarter last year, which suggests a positive year-over-year growth rate of 27.8%. The business is expected to issue its next quarterly earnings results after the market closes on Tuesday, February 13th.
On average, analysts expect that Trupanion will report full-year sales of $65.60 million for the current fiscal year, with estimates ranging from $241.40 million to $242.00 million. For the next year, analysts anticipate that the firm will post sales of $295.10 million per share, with estimates ranging from $291.70 million to $298.50 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Trupanion.
TRUP has been the topic of a number of research analyst reports. BidaskClub upgraded Trupanion from a “hold” rating to a “buy” rating in a research report on Monday, December 18th. CL King initiated coverage on Trupanion in a research report on Tuesday, November 21st. They set a “neutral” rating on the stock. Canaccord Genuity reiterated a “buy” rating and set a $35.00 target price (up previously from $29.00) on shares of Trupanion in a research report on Tuesday, October 31st. Finally, Zacks Investment Research upgraded Trupanion from a “hold” rating to a “buy” rating and set a $37.00 target price on the stock in a research report on Wednesday, November 8th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $28.83.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. First Mercantile Trust Co. purchased a new position in shares of Trupanion during the fourth quarter worth about $129,000. JPMorgan Chase & Co. purchased a new position in shares of Trupanion during the third quarter worth about $143,000. Voya Investment Management LLC purchased a new position in shares of Trupanion during the second quarter worth about $215,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Trupanion during the third quarter worth about $221,000. Finally, Wells Fargo & Company MN grew its holdings in shares of Trupanion by 13.5% during the second quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock worth $252,000 after buying an additional 1,342 shares during the last quarter. 63.76% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Trupanion (NASDAQ TRUP) opened at $32.05 on Thursday. The company has a current ratio of 1.87, a quick ratio of 1.87 and a debt-to-equity ratio of 0.15. Trupanion has a 52-week low of $13.88 and a 52-week high of $36.88. The company has a market capitalization of $962.78, a PE ratio of -356.11 and a beta of 0.34.
TRADEMARK VIOLATION NOTICE: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/02/08/65-60-million-in-sales-expected-for-trupanion-inc-trup-this-quarter.html.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.